ANDA 88605, held by Sandoz Inc. Phentermine Hydrochloride.
As of Nov 16, 2026, ANDA 88605 (Phentermine Hydrochloride), held by Sandoz Inc, was first approved by FDA on Sep 28, 1987, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 28, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phentermine Hydrochloride30MG · tablet;oral | Phentermine Hydrochloride | Discontinued |
| May 31, 2017 | Supplement 14Labeling | Approved | None posted |
| May 31, 2017 | Supplement 15Labeling · Standard review | Approved | None posted |
| Jul 31, 2001 | Supplement 7Manufacturing | Approved | None posted |
| Jul 31, 2001 | Supplement 8Manufacturing | Approved | None posted |
| Jul 31, 2001 | Supplement 9Manufacturing | Approved | None posted |
| Jul 31, 2001 | Supplement 10Manufacturing | Approved | None posted |
| Mar 20, 2001 | Supplement 5Manufacturing | Approved | None posted |
| Mar 20, 2001 | Supplement 6Labeling | Approved | None posted |
| Sep 15, 2000 | Supplement 3Manufacturing | Approved | None posted |
| Sep 15, 2000 | Supplement 4Labeling | Approved | None posted |
| Jun 25, 1993 | Supplement 1Labeling | Approved | None posted |
| Sep 28, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters